1. Home
  2. NAC vs ANIP Comparison

NAC vs ANIP Comparison

Compare NAC & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAC
  • ANIP
  • Stock Information
  • Founded
  • NAC 1998
  • ANIP 2001
  • Country
  • NAC France
  • ANIP United States
  • Employees
  • NAC N/A
  • ANIP N/A
  • Industry
  • NAC Investment Managers
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • NAC Finance
  • ANIP Health Care
  • Exchange
  • NAC Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • NAC 1.6B
  • ANIP 1.4B
  • IPO Year
  • NAC N/A
  • ANIP N/A
  • Fundamental
  • Price
  • NAC $10.93
  • ANIP $66.30
  • Analyst Decision
  • NAC
  • ANIP Strong Buy
  • Analyst Count
  • NAC 0
  • ANIP 9
  • Target Price
  • NAC N/A
  • ANIP $80.56
  • AVG Volume (30 Days)
  • NAC 307.3K
  • ANIP 277.5K
  • Earning Date
  • NAC 01-01-0001
  • ANIP 08-05-2025
  • Dividend Yield
  • NAC 4.33%
  • ANIP N/A
  • EPS Growth
  • NAC N/A
  • ANIP N/A
  • EPS
  • NAC N/A
  • ANIP N/A
  • Revenue
  • NAC N/A
  • ANIP $674,068,000.00
  • Revenue This Year
  • NAC N/A
  • ANIP $30.84
  • Revenue Next Year
  • NAC N/A
  • ANIP $7.39
  • P/E Ratio
  • NAC N/A
  • ANIP N/A
  • Revenue Growth
  • NAC N/A
  • ANIP 30.27
  • 52 Week Low
  • NAC $9.32
  • ANIP $52.50
  • 52 Week High
  • NAC $11.21
  • ANIP $77.00
  • Technical
  • Relative Strength Index (RSI)
  • NAC 37.39
  • ANIP 55.06
  • Support Level
  • NAC $11.16
  • ANIP $63.60
  • Resistance Level
  • NAC $11.24
  • ANIP $66.97
  • Average True Range (ATR)
  • NAC 0.06
  • ANIP 2.01
  • MACD
  • NAC -0.03
  • ANIP 0.10
  • Stochastic Oscillator
  • NAC 0.00
  • ANIP 57.64

About NAC Nuveen California Quality Municipal Income Fund

Nuveen California Quality Municipal Income Fund is a diversified closed-end management investment company. Its objective is to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal and California state income taxes. It invests majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: